Skip to content
evitria – Recombinant antibody expression in CHO cells
  • Newsletter
  • Blog
      • About evitria
      • About Evitria
      • Antibody journal
        • Antibody reformatting and engineering
        • CHO cells – first choice for antibody production
        • Scalability & Reproducibility
        • Transient Antibody Production
      • Antibody journal
        • Antibody reformatting and engineering
        • Blog
        • bYlok® bispecific pairing technology in bsAb production
        • Encyclopedia Overview
        • Publications
        • Scalability & Reproducibility
        • Transient Antibody Expression
        • Why CHO cells remain the first choice for antibody production
      • Contact
      • Contact
      • Data Protection
      • Download bYlok® Bispecific Pairing Technology by Lonza
      • Encyclopedia
      • Events
      • Events
      • FAQs
      • FAQs
      • High-Throughput Antibody Production Service
      • HTML Sitemap
      • Integral Molecular
      • LinkedIn Journal Club
      • LinkedIn Journal Club
      • Newsletter
      • Newsletter
      • Newsletter
      • Partnerships
        • Atlas Antibodies
        • Lonza
        • ProBioGen
        • Rapid Novor
      • Partnerships
        • Atlas Antibodies – Selected partner
        • Lonza – Selected partner
        • ProBioGen – Selected partner
        • Rapid Novor: Selected Partner
      • Poster Download: antibody development and quality control by mass spectometry
      • Privacy Policy
      • Publications
      • Recombinant Antibody Expression Service
        • Afucosylated Antibody Expression Service
        • Bispecific Antibody Production Service
        • Fc-Silenced Antibody Expression Service
        • Recombinant Protein Expression Service
      • Sitemap
      • Solutions
        • Acadamic research institutions
        • Government-funded research institutions
        • Therapeutics development
      • Testpage
      • Thank you
      • Therapeutics development
      • Welcome to evitria
      • Startseite
      • Recombinant Antibody Expression Service
        • Afucosylated Antibody Expression Service
        • Fc-Silenced Antibody Expression Service
        • Bispecific Antibody Production Service
        • Recombinant Protein Expression Service
      • LottiAnimationTest
      • Privacy Policy
      • Sample Page
Contact
  • Expression Services

    Recombinant Antibody Production

    Production of Afucosylated Antibodies

    Production of Fc-silenced Antibodies

    Bispecific Antibody Production

    Other Protein Production

  • Our Technologies

      Our Technologies

      STR – True Fc Silencing Technology

      GlymaxX® – Glycoengineering and ADCC Enhancement

      High-Throughput Antibody Production Service

      Our Technologies
  • About us

      About us

      About Evitria

      Events

      Partnerships

      FAQs

      Contact

  • Antibody Journal

      Antibody Journal

      Features

      Transient Antibody Production

      CHO cells – first choice for antibody production

      Antibody reformatting and engineering

      Scalability & Reproducibility

      Antibodies

      Recombinant Antibodies

      Afucosylated antibodies

      Fc-silenced antibodies

      Bispecific/multispecific antibodies

      Resources

      Blog

      Encyclopedia

      Publications

Let’s get in contact
  • LinkedIn
  • YouTube
  1. evitria – Recombinant antibody expression in CHO cells
  2. 2019

2019

  • CHO Cells
  • Monoclonal antibodies
  • News
  • Recombinant antibodies

  • In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection

    technik Avatar
    March 30, 2025
  • Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

    technik Avatar
    March 30, 2025
  • Disruption of Sema3A/Plexin‐A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination

    technik Avatar
    March 30, 2025
  • Functionalized Tobacco Mosaic Virus Coat Protein Monomers and Oligomers as Nanocarriers for Anti-Cancer Peptides

    technik Avatar
    March 30, 2025
  • Subcutaneous administration of neutralizing antibodies to endothelial monocyte-activating protein II attenuates cigarette smoke-induced lung injury in mice

    technik Avatar
    March 30, 2025
  • Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life

    technik Avatar
    March 30, 2025
  • A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions

    technik Avatar
    March 30, 2025
  • Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis

    technik Avatar
    March 30, 2025
  • An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model

    technik Avatar
    March 30, 2025
  • Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner

    technik Avatar
    March 30, 2025
1 2
Next Page→

4 weeks from sequence to recombinant antibody.

  • LinkedIn
  • YouTube
  • Privacy Policy

©2025 evitria ag

PowerEd by

We Value Your Privacy

This website uses cookies to enhance your browsing experience and provide personalized services. We require your consent to set these cookies on your device.

Your Privacy

This site uses tracking technologies. You may opt in or opt out of the use of these technologies.

Marketing cookies and services are used to deliver personalized advertisements, promotions, and offers. These technologies enable targeted advertising and marketing campaigns by collecting information about users' interests, preferences, and online activities.

Analytics cookies and services are used for collecting statistical information about how visitors interact with website. These technologies provide insights into website usage, visitor behavior, and site performance to understand and improve the site and enhance user experience.

Personalization cookies enable the website to remember your choices and provide enhanced, more personal features. These cookies may track your preferences and show you relevant content based on your browsing patterns.

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features.

Essential cookies are necessary for the website to function properly. These cookies ensure basic functionalities and security features of the website.